Taurultam - CAS 38668-01-8
Catalog number: B0084-114907
Category: Inhibitor
Not Intended for Therapeutic Use. For research use only.
Molecular Formula:
Molecular Weight:
Taurultam is a compound with antibacterial activity. It has shown inhibitory effect on cell proliferation and cell adhesion in angiogenesis.
Ordering Information
Catalog Number Size Price Stock Quantity
B0084-114907 100 mg $198 In stock
Bulk Inquiry
White Solid
1,2,4-Thiadiazinane 1,1-dioxide
Boiling Point:
273.8±50.0 °C at 760 mmHg
Melting Point:
1.3±0.1 g/cm3
Canonical SMILES:
1.Taurolidine and congeners activate hTRPA1 but not hTRPV1 channels and stimulate CGRP release from mouse tracheal sensory nerves.
Kichko TI1, Pfirrmann RW2, Reeh PW1. Pharmacol Res Perspect. 2016 Feb 1;4(1):e00204. doi: 10.1002/prp2.204. eCollection 2016.
Taurolidine has long been in clinical use as an antimicrobial irrigation that does not impede wound healing. It can even be administered intravenously (30 g/day) to treat sepsis or to exert newly recognized antineoplastic actions. Only one irritant effect is reported, that is, to temporarily induce burning pain of unknown origin when applied to body cavities or peripheral veins. The structure of the molecule suggested the chemoreceptor channel TRPA1 as a potential target, which was verified measuring stimulated CGRP release from sensory nerves of the isolated mouse trachea and calcium influx in hTRPA1-transfected HEK293 cells. With both methods, the concentration-response relationship of taurolidine exceeded the threshold value below 500 μmol/L and 100 μmol/L, respectively, and reached saturation at 1 mmol/L. The clinical 2% taurolidine solution did not evoke greater or longer lasting responses. The reversible tracheal response was abolished in TRPA1(-/-) but retained in TRPV1(-/-) mice.
2.The pharmacokinetics of taurolidine metabolites in healthy volunteers.
Gong L1, Greenberg HE, Perhach JL, Waldman SA, Kraft WK. J Clin Pharmacol. 2007 Jun;47(6):697-703. Epub 2007 Mar 29.
Taurolidine is an experimental antibacterial and antiendotoxic compound whose clinical utility as an antitumor agent is being investigated in human clinical trials. Taurolidine in aqueous solution exists in equilibrium with taurultam. Taurultam is subsequently transformed to taurinamide. The pharmacokinetic profiles of these metabolites are not well established. In this study, 18 healthy volunteers were administered 5.0 g of taurolidine in 250 mL of 5% polyvinylpyrrolidone in water over 2, 1, or 0.5 hours by intravenous infusion in a parallel-group design. All subjects noted discomfort at the infusion site, although there were no serious adverse events. t(max) generally occurred at the end of infusion for taurinamide, whereas that of taurultam was reached before completion of infusion. The taurolidine metabolite taurultam demonstrated a shorter half-life and lower systemic exposure than taurinamide. Shortening of infusion duration increased the C(max) and AUC of taurultam.
3.Studies of the thiadiazine, taurolidine-I. Identification of the molecular species present in aqueous solutions by (1)H- and (13)C-NMR spectroscopy.
Hood HT1, Smail GA, Skellern GG, Jindal DP, Browne MK, Pfirrmann RW. Talanta. 1994 Jan;41(1):107-13.
The equilibria in deuterium oxide solutions of the diamine, 4,4'-methylenebis(tetrahydro-1,2,4-thiadiazine-1,1-dioxide), were studied using highfield (1)H- and (13)C-NMR with the aid of solutions of tetrahydro-2H-1,2,4-thiadiazine-1,1-dioxide (taurultam), its two N-methyl detivatives and methylene glycol. Comparison of the (1)H-NMR spectrum of taurolidine with the one obtained from a mixture of taurultam and methylene glycol indicated that the same equilibria exists in both these solutions. It was concluded that taurolidine, taurultam and its 4-hydroxymethyl adduct and methylene glycol are the major components present. To facilitate the interpretation of the (13)C-spectra, (13)C-enriched methylene glycol was added to solutions of taurultam. The (13)C-studies confirmed the (1)H-NMR study.
4.Structural investigation of a new organic antiseptic: Taurolidine A spectroscopic study of its stability and equilibria in various solvents.
Erb F1, Febvay N, Imbenotte M. Talanta. 1982 Nov;29(11 Pt 1):953-8.
(1)H and (13)C NMR investigations of aqueous solutions of Taurolidine and Tauroflex have been made to determine their stability. This study revealed two successive equilibria, leading particularly to Taurultam-methylol (in 15% proportion) from a 0.5% Taurolidine solution. The methylol derivative is supposed to be the component active against bacteria and their endotoxins.
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related Products

CAS 7554-65-6 4-Methylpyrazole

(CAS: 7554-65-6)

4-Methylpyrazole is a competitive inhibitor of alcohol dehydrogenase, which catalyzes metabolism of ethylene glycol and methanol to toxic metabolites. It is use...

BMS 182264
(CAS: 127749-54-6)

BMS 182264 is a bio-active chemical, but few detailed information has been published yet.

CAS 22232-54-8 Carbimazole

(CAS: 22232-54-8)

Carbimazole is used to treat hyperthyroidism. Carbimazole is a pro-drug as after absorption it is converted to the active form, methimazole. Methimazole prevent...

CAS 253771-21-0 AR-C 102222

AR-C 102222
(CAS: 253771-21-0)

AR-C 102222 has been found to be an iNOS inhibitor and show antinociceptive and anti-inflammatory activity in rodent pain models.

(CAS: 256477-09-5)

UK-371804 is a novel and selective inhibitors of urokinase plasminogen activator (uPA). UK-371804 exhibits excellent enzyme potency (Ki 10 nM) and selectivity p...


Gly-Phe-Arg, a superpotent synthetic tripeptide, mimics the mud-crab pumping pheromone.

(CAS: 1628428-01-2)

PKR-IN-2 is a pyruvate kinase (PKR) activator. IC50: PKR (R510Q) <100 nM

CAS 2398-81-4 Nicotinic acid N-oxide

Nicotinic acid N-oxide
(CAS: 2398-81-4)

Nicotinic acid N-oxide is used to treat hyperlipoidemia.

CAS 80-77-3 Chlormezanone

(CAS: 80-77-3)

Chlormezanone, a non-benzodiazepine that is used in the management of anxiety. It has been suggested for use in the treatment of muscle spasm.

Aftobetin Hydrochloride
(CAS: 1353222-83-9)

Aftobetin, also known as ANCA11 and NCE-11, is a novel amyloid–binding compound applied topically in the form of an ophthalmic ointment. Aftobetin may be of use...

Cgp 43902A
(CAS: 124076-31-9)

Cgp 43902A is a bio-active molecular, but no detailed information has been published yet.

CAS 1018927-63-3 EG 00229

EG 00229
(CAS: 1018927-63-3)

EG 00229 is a neuropilin 1 (NRP1) receptor antagonist, inhibiting VEGFA binding to the NRP1 b1 domain.

CAS 151988-33-9 Ac2-26

(CAS: 151988-33-9)

Ac2-26 is an annexin/lipocortin 1-mimetic peptide that inhibits leukocyte extravasation. It promotes detachment of neutrophils from activated mesenteric endothe...

CAS 71610-00-9 Cephalomannine

(CAS: 71610-00-9)

Cephalomannine is an active anti-cancer agent obtained from Taxus yunnanensis and has an antineoplastic effect on tumors found in mice.

CAS 1014-70-6 Simetryn

(CAS: 1014-70-6)

Simetryn, a methylthiotriazine derivative, is a herbicide which is commonly used in rice paddy. LC50: 16.9-3.70 mg/L (79.3-17.4 microM).

CAS 41451-75-6 Bruceantin

(CAS: 41451-75-6)

Bruceantin is first isolated from Brucea antidysenterica, a tree used in Ethiopia for the treatment of cancer, and activity was observed against B16 melanoma, c...

CAS 69207-52-9 McN3716

(CAS: 69207-52-9)

An inhibitor of carnitine palmitoyltransferase I (CPT-1)

(CAS: 848444-16-6)

FR-217840 is a matrix metalloproteinase inhibitor. It can suppress joint destruction. FR217840 may have potential as a novel anti-rheumatic drug.

(CAS: 1224977-86-9)

AM-206 is a bio-active chemical but no detailed data has been published yet.

(CAS: 1004523-72-1)

VRX-806 is a novel nonnucleoside reverse transcriptase inhibitor (NNRTI) with potent in vitro activity against wild-type and NNRTI-resistant HIV-1.

Chemical Structure

CAS 38668-01-8 Taurultam

Quick Inquiry

Verification code

Featured Items